Title |
Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea
|
---|---|
Published in |
Chinese Medicine, November 2013
|
DOI | 10.1186/1749-8546-8-21 |
Pubmed ID | |
Authors |
PatrickYing-Kit Yue, Yi-Yi Wong, KayYuen-Ki Wong, Yeuk-Ki Tsoi, KelvinSze-Yin Leung |
Abstract |
Antrodia cinnamomea (AC) is an endemic mushroom species of Taiwan, and has been demonstrated to possess diverse biological and pharmacological activities, such as anti-hypertension, anti-hyperlipidemia, anti-inflammation, anti-oxidation, anti-tumor, and immunomodulation. This review focuses on the inhibitory effects of AC on hepatitis, hepatocarcinoma, and alcohol-induced liver diseases (e.g., fatty liver, fibrosis). The relevant biochemical and molecular mechanisms are addressed. Overall, this review summarizes the hepatoprotective activities in vitro and in vivo. However, there is no doubt that human and clinical trials are still limited, and further studies are required for the development of AC-related products. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Science communicators (journalists, bloggers, editors) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Sri Lanka | 1 | 3% |
Unknown | 34 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 23% |
Student > Bachelor | 6 | 17% |
Student > Ph. D. Student | 4 | 11% |
Other | 3 | 9% |
Student > Master | 3 | 9% |
Other | 6 | 17% |
Unknown | 5 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 9 | 26% |
Biochemistry, Genetics and Molecular Biology | 6 | 17% |
Medicine and Dentistry | 4 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 6% |
Chemical Engineering | 2 | 6% |
Other | 2 | 6% |
Unknown | 10 | 29% |